<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-pharmaceutics-10-00039">
 <label>71.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dalpiaz</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Paganetto</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Pavan</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Fogagnolo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Medici</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Beggiato</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Perrone</surname>
    <given-names>D.</given-names>
   </name>
  </person-group>
  <article-title>Zidovudine and ursodeoxycholic acid conjugation: Design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system</article-title>
  <source>Mol. Pharm.</source>
  <year>2012</year>
  <volume>9</volume>
  <fpage>957</fpage>
  <lpage>968</lpage>
  <pub-id pub-id-type="doi">10.1021/mp200565g</pub-id>
  <?supplied-pmid 22356133?>
  <pub-id pub-id-type="pmid">22356133</pub-id>
 </element-citation>
</ref>
